CI Investments Inc
ACOR

CI Investments Inc’s Acorda Therapeutics ACOR Stock Holding History

CI Investments Inc’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,322
Closed -$455K – 650
2019
Q3 		$455K Buy
+1,322
New +$719K ﹤0.01% 505

Other funds holding ACOR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

CI Investments Inc's ACOR Position: Q4 2019 in Review

CI Investments Inc sold out of Acorda Therapeutics (ACOR) in Q4 2019, closing a stake of 1,322 shares — an estimated $455K sold.

CI Investments Inc first reported a position in ACOR in Q3 2019 and held it in 1 quarter. The position peaked at $455K in Q3 2019. 121 funds tracked by Wall St. Rank hold ACOR as of Q4 2019.

  • CI Investments Inc reported no remaining Acorda Therapeutics position as of Q4 2019 after selling out during the quarter.
  • CI Investments Inc sold 1,322 Acorda Therapeutics shares in Q4 2019, an estimated $455K.
  • CI Investments Inc first reported a position in Acorda Therapeutics in Q3 2019 and held it in 1 quarter.
  • CI Investments Inc's Acorda Therapeutics position peaked at $455K in Q3 2019.
  • 121 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2019.

Based on CI Investments Inc's 13F filing for Q4 2019, filed 11 Feb 2020.